Financials
Value Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income 85.49 M63.54 M83.81 M105.65 M 338.49 M Non-Operating Income, Total -7.79 M23.13 M17.84 M3.43 M 36.61 M Interest expense, net of interest capitalized 36.95 M29.26 M17.89 M17.81 M 101.91 M Non-Operating Income, excl. Interest Expenses -39.13 M-6.13 M-6.52 M-14.37 M -66.16 M Unusual income/expense -5.61 M—6.47 M-7 000 — Pretax income 42.93 M31.96 M72.39 M87.83 M 235.12 M Equity in earnings ———— — Taxes 10.04 M11.37 M15.47 M19.16 M 56.04 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 32.9 M20.6 M56.92 M68.67 M 179.08 M Discontinued operations ———— — Net income 32.9 M20.6 M56.92 M68.67 M 179.08 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 32.9 M20.6 M56.92 M68.67 M 179.08 M Basic earnings per share (Basic EPS) 0.190.10.290.35 0.93 Diluted earnings per share (Diluted EPS) 0.190.090.280.34 0.9 Average basic shares outstanding 171.42 M177 M197.87 M198.57 M — Diluted shares outstanding 174.95 M181.44 M203.28 M203.55 M — EBITDA 364.41 M361.83 M373.96 M414.38 M 1.51 B EBIT 361.14 M337.47 M351.45 M392.16 M 1.44 B Cost of revenue 437 K705 K2.05 M349 K 3.54 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 23.39 M24.36 M22.5 M22.22 M 92.47 M